Table 1.
Baseline Demographics and Clinical Characteristics
| Characteristic | Study population (n = 183) |
|---|---|
| Age, y, mean ± SD | 58.1 ± 18 |
| Sex, n (%) | |
| Male | 95 (51.9) |
| Female | 88 (48.1) |
| BMI, kg/m2, mean ± SD | 28.7 ± 18 |
| Obesity, BMI ≥30 kg/m2, n (%) | 68 (37.2) |
| Diagnosis, n (%) | |
| Achalasia type I | 13 (7.1) |
| Achalasia type II | 110 (60.1) |
| Achalasia type III | 20 (10.9) |
| EGJOO | 20 (10.9) |
| Jackhammer esophagus | 18 (9.8) |
| Diffuse esophageal spasm | 2 (1.1) |
| Duration of symptoms, y, mean ± SD | 5.9 ± 4.7 |
| Proton pump inhibitor usage, n (%) | 29 (15.8) |
| Eckardt Score, mean ± SD | |
| Weight loss | 1.7 ± 1.0 |
| Dysphagia | 2.3 ± 0.7 |
| Chest pain | 1.1 ± 0.9 |
| Regurgitation | 2.1 ± 0.8 |
| Total score | 7.2 ± 1.9 |
EGJOO, esophagogastric junctional outlet obstruction.